Share This

Public company info - Fusen Pharmaceutical Company Limited , 01652.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Fusen Pharmaceutical Company Limited, 01652.HK - Cash Flow 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12
Net Cash Flow from Operating Activities 171,076 41,349 85,722 151,174 186,456 77,502
Net Cash Flow from Return on Investments & Servicing of Finance -9,191 -12,557 -14,841 -34,631 -161,362 -15,361
 Interest Received 2,889 1,966 2,205 20,944 36,015 41,207
 Interest Paid -8,935 -9,168 -15,910 -30,558 -40,101 -42,416
 Dividend Received 0 0 0 0 0 0
 Dividend Paid -3,145 -5,355 -1,136 -25,017 -157,276 -14,152
 Others 0 0 0 0 0 0
Taxes (Paid) / Refunded -17,869 -20,959 -22,904 -17,968 -14,111 -7,698
Net Cash Flow from Investing Activities -71,086 -263,218 -92,928 434,570 291,651 25,978
 Additions to Fixed Assets -58,645 -200,270 -104,353 -9,078 -19,977 -27,837
 Disposal of Fixed Assets 82 30 0 0 1,469 124
 Increase in Investments -76,456 -62,978 0 0 0 0
 Decrease in Investments 63,933 0 0 0 0 0
 Net Cash Flow with Related Parties -330 -31 -4,961 -1,115 60,670 14,022
 Others 330 31 16,386 444,763 249,489 39,669
Net Cash Flow before Financing Activities 72,930 -255,385 -44,951 533,145 302,634 80,421
Net Cash Flow from Financing Activities -104,250 19,969 117,894 -302,795 -90,813 -75,057
 New Loans 210,873 0 190,000 391,600 567,670 864,011
 Loans Repayment -220,000 -100,000 -391,600 -600,678 -719,153 -774,400
 Fixed Income/Debt Instruments 0 0 0 0 0 547,290
 Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 -339,980
 Equity Financing 0 120,000 324,455 0 0 0
 Net Cash Flow with Related Parties -330 -31 -4,961 -1,115 60,670 14,022
 Others -94,793 0 0 -92,602 0 -386,000
Increase(Decrease) in Cash & Cash Equivalents -31,320 -235,416 72,943 230,350 211,821 5,364
Cash & Cash Equivalents at Beginning of Year 331,044 561,108 474,621 244,390 32,569 27,205
Net Cash Flow due to Change in Exchange Rate/Others -2,686 5,352 13,544 -119 0 0
Cash & Cash Equivalents at End of Year 297,038 331,044 561,108 474,621 244,390 32,569
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.